|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/36 | (2006.01) |
| A61P 7/04 | (2018.01) | ||
| A61P 7/04 | (2006.01) | ||
| A61K 38/36 | (2013.01) |
| (11) | Patento numeris | 3648787 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18746457.3 |
| Europos patento paraiškos padavimo data | 2018-07-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-05-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-10-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/041319 |
| Data | 2018-07-09 |
| (87) | Numeris | WO 2019/010496 |
| Data | 2019-01-10 |
| (30) | Numeris | Data | Šalis |
| 201762530024 P | 2017-07-07 | US | |
| 201762546999 P | 2017-08-17 | US |
| (72) |
CHAPMAN, Miranda , US
EWENSTEIN, Bruce , US
PLODER, Bettina , AT
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | TREATMENT OF PATIENTS WITH SEVERE VON WILLEBRAND DISEASE UNDERGOING ELECTIVE SURGERY BY ADMINISTRATION OF RECOMBINANT VWF |
| TREATMENT OF PATIENTS WITH SEVERE VON WILLEBRAND DISEASE UNDERGOING ELECTIVE SURGERY BY ADMINISTRATION OF RECOMBINANT VWF |